Kidney Cancer

Kidney Cancer Following Renal Transplantation Characterized

Kidney Cancer Following Renal Transplantation Characterized

By

Renal cell carcinoma (RCC) is more likely to develop in male and white patients and those with a history of RCC.

Obesity Ups Bladder, Kidney Cancer Risk in Men

Obesity Ups Bladder, Kidney Cancer Risk in Men

By

As body mass index increases, so does the risk of kidney and bladder cancers in men and stomach, ovarian, and colon cancers in women.

Prostate Cancer Patients Face Higher Risk of Second Malignancies

Prostate Cancer Patients Face Higher Risk of Second Malignancies

By

Study reveals a 2-fold greater likelihood of primary kidney and bladder cancer compared with men in the general population.

Visceral Fat Area Predicts Kidney Cancer Subtype

Visceral Fat Area Predicts Kidney Cancer Subtype

By

Increased abdominal adiposity is associated with a greater likelihood of clear-cell renal cell carcinoma.

Partial Nephrectomy Superior Despite Kidney Tumor Size

Partial Nephrectomy Superior Despite Kidney Tumor Size

By

Renal function is preserved better compared with radical nephrectomy even when tumors are larger than the traditional 4 cm cutoff.

Renal Tumor Risk Higher in Lithium-Treated Patients

Renal Tumor Risk Higher in Lithium-Treated Patients

By

Renal tumors occur at a frequency 7.5 times greater in lithium-treated patients than in the general population, French study shows.

Nephron Sparing Surgery Okay for Tumors in Transplanted Kidneys

Nephron Sparing Surgery Okay for Tumors in Transplanted Kidneys

By

At last follow-up, 41 of 43 patients who underwent partial nephrectomy did not require dialysis.

High Cholesterol Predicts Better RCC Outcomes

High Cholesterol Predicts Better RCC Outcomes

By

Patients with levels of 161.5 mg/dL or greater had a 43% decreased risk of death from renal cell carcinoma than those with lower levels.

Pre-Existing HTN Predicts Better Survival in Sunitinib Recipients

Pre-Existing HTN Predicts Better Survival in Sunitinib Recipients

By

The finding emerged from a French study of 213 patients with metastatic renal cell carcinoma.

Autologous Immunotherapy for mRCC Shows Promise

Autologous Immunotherapy for mRCC Shows Promise

By

Added to sunitinib, it prolongs progression-free and overall survival in patients with unfavorable-risk metastatic renal cell carcinoma.

TSC-Related Pediatric Renal Tumors Respond to Everolimus

TSC-Related Pediatric Renal Tumors Respond to Everolimus

By

Drug found to benefit children with renal angiomyolipomas associated with tuberous sclerosis complex.

Shorter RCC Recurrence Time Ups Risk of Cancer-Specific Death

Shorter RCC Recurrence Time Ups Risk of Cancer-Specific Death

By

The risk of cancer-specific death at 1 year was 48% and 23% for patients whose disease recurred at 3 months and 3 years, respectively.

Renal Mass Biopsy Underused in U.S.

Renal Mass Biopsy Underused in U.S.

By

The proportion of patients undergoing the procedure has stayed at 6%-7% annually.

Study Identifies RCC Predictors

Study Identifies RCC Predictors

By

Larger tumor size, male sex, and higher nephrometry score indicate a greater likelihood that a renal mass is malignant, researchers report.

Scoring System May ID Best Candidates for SRM Active Surveillance

Scoring System May ID Best Candidates for SRM Active Surveillance

By

The DISSRM score may be an easy-to-calculate surrogate for competing risk mortality.

Predictors of Post-Nephrectomy Readmission ID'd

Predictors of Post-Nephrectomy Readmission ID'd

By

Open procedures, preoperative dialysis, and higher ASA score were significant predictors of readmission after radical nephrectomy.

RCC Surveillance Guidelines Need Improvement

RCC Surveillance Guidelines Need Improvement

By

Following guidelines from the AUA and NCCN would miss many cases of disease recurrence following surgery, study suggests.

Lower SES Predicts More Advanced Renal Cancer at Diagnosis

Lower SES Predicts More Advanced Renal Cancer at Diagnosis

By

Patients of lower socioeconomic status present with larger tumors, higher T stage, positive lymph nodes.

Statins May Improve RCC Surgery Outcomes

By

Statin use decreases the risk of disease progression after surgery for localized RCC.

Statins Reduce Kidney Cancer Progression

Statins Reduce Kidney Cancer Progression

Reduced risk of progression of localized renal cell carcinoma observed in patients on statins.

Cryoablation Offers Long-Term RCC Control

Cryoablation Offers Long-Term RCC Control

By

The 5-year disease-free and cancer-specific survival rates were 94.7% and 100%, respectively.

Radiofrequency Ablation May Be a Valid Approach for RCC

Radiofrequency Ablation May Be a Valid Approach for RCC

By

Study shows it can provide durable oncologic control with a low risk of tumor recurrence.

Elevated CKD Risk May Remain Despite Partial Nephrectomy

Elevated CKD Risk May Remain Despite Partial Nephrectomy

By

Risk is not eliminated if patients have risk factors for chronic kidney disease, such as hypertension and diabetes.

Renal Mass Biopsy Seldom Used Pre-RCC Surgery

Renal Mass Biopsy Seldom Used Pre-RCC Surgery

By

Only 17% and 20% of patients undergoing radical or partial nephrectomy, respectively, had a renal mass biopsy in advance of surgery.

Kidney Remaining After Donor Nephrectomy Increases in Size

Kidney Remaining After Donor Nephrectomy Increases in Size

By

Increment in renal parenchymal volume occurs within days after a kidney is removed from a living donor.

Percutaneous Biopsy Accurately Diagnoses Urothelial Carcinoma

Percutaneous Biopsy Accurately Diagnoses Urothelial Carcinoma

By

Technique provides a tissue diagnosis in 88% of cases, according to a study.

Renal Ablation Safe, Effective for Elderly Patients

Renal Ablation Safe, Effective for Elderly Patients

By

Data support the use of percutaneous cryoablation and radiofrequency ablation for small renal tumors.

Renal Tumor Ablation Via the Liver Is Safe, Effective

Renal Tumor Ablation Via the Liver Is Safe, Effective

By

In a small study, researchers show that ultrasound-guided transhepatic radiofrequency ablation is technically feasible.

CDC: Cancer Prevention Services Below Target Goals

CDC: Cancer Prevention Services Below Target Goals

Increasing health insurance coverage and access to usual source of care necessary to meet targets.

Personalized Medicine in 2014

Personalized Medicine in 2014

By

The term "personalized medicine" remains an overused promise to apply specific treatment plans.

Sign Up for Free e-newsletters